Part 1

Summary

The meeting convenes with full attendance, led by Dr. Rert. The agenda and previous meeting minutes are approved. Dr. Everly presents an update on forming a consortium to enhance COVID-19 vaccine production in the region, highlighting a country with existing facilities that can be adapted for this purpose. Challenges in funding and distribution to remote areas are noted, with calls for support from global donors. Notable participants in the consortium include directors from the UK and China’s public health sectors, as well as Tom Kaki from the Regional Academy of Sciences, aiming to ensure diverse community representation.

Takeaways

• 📅 The meeting was called to order with all committee members present.
• ✅ The agenda for the meeting was approved unanimously after a motion and a second.
• 📝 Meeting minutes from July 29th were also approved following a motion and second.
• 💉 Dr. Everly presented an update on forming a Consortium to increase COVID-19 vaccine production.
• 🌍 A country with existing vaccine manufacturing facilities was identified to expand production for COVID-19 vaccines.
• 💰 Funding and distribution issues in remote areas pose challenges for vaccine accessibility.
• 🤝 Regional countries are encouraged to seek funding from global donors to support vaccine initiatives.
• 📞 Dr. Abbe agreed to reach out to organizations involved in vaccine research and development.
• 🌐 The director of the UK Public Health rapid support team and the director of Public Health in China have agreed to join the Consortium.
• 🔬 Tom Kariu from the Regional Academy of Sciences will also participate in the Consortium efforts.

Q & A

What was the purpose of the meeting?

The meeting was called to discuss the formation of a Consortium aimed at increasing vaccine production, specifically for COVID-19.

Who took attendance at the meeting?

M Law took attendance during the meeting.

What agenda item was approved during the meeting?

The agenda for the meeting was approved after a motion and a second were made.

What specific vaccine was the focus of Dr. Everly's update?

Dr. Everly provided an update on the COVID-19 vaccine and efforts to increase its production in the region.

What challenges did Dr. Everly mention regarding vaccine production?

Dr. Everly mentioned challenges with funding and distribution in remote areas as obstacles to increasing vaccine production.

Which countries have been identified as having facilities to produce the COVID-19 vaccine?

A country with existing vaccine production facilities has been identified, which could be expanded to produce the COVID-19 vaccine.

Who agreed to participate in the Consortium?

The director of the UK Public Health rapid support team, the director of Public Health in China, and Tom Kariu, the director of programs at the Regional Academy of Sciences, agreed to participate.

What did Dr. Everly say about the potential for community involvement?

Dr. Everly emphasized the importance of having many communities in the region voice their needs and concerns in the Consortium.

What funding challenges did Dr. Everly highlight?

Dr. Everly highlighted the need for Regional countries to seek funding from Global donors to support the vaccine production efforts.

What action did Dr. Abbe agree to take regarding the Consortium?

Dr. Abbe agreed to reach out to representatives from organizations involved in vaccine research and development to seek support for the Consortium.